Free Medical Consultation on Sunday 10 to 7 pm

Please visit Aziziyah Medical Centre

for For evaluation of 

1.Medical Consultation 

2.Diseses of blood 

3.Complete cancer care including Screening quick work up and treatment at an affordable cost. 

For more infor.can call.... 6006052150

or visit ...www.aziziyahmedical.blogspot.com

تمباکو اور کینسر ۔۔۔ زرا غور کریں۔

بھارت میں پھیپھڑوں کا کینسر ایک عام اور جان لیوا مرض ہے۔ یہاں کچھ اہم اعداد و شمار دیے جا رہے ہیں:واقعات: پھیپھڑوں کا کینسر بھارت میں مردوں میں دوسرا اور عورتوں میں پانچواں سب سے عام کینسر ہے۔ ہر سال تقریباً 70,000 سے 80,000 نئے کیسز رپورٹ ہوتے ہیں۔اموات: پھیپھڑوں کا کینسر مردوں میں کینسر سے متعلق اموات کی سب سے بڑی وجہ ہے۔ ہر سال تقریباً 63,000 سے 65,000 اموات ہوتی ہیں۔عمر اور جنس: پھیپھڑوں کا کینسر زیادہ تر 60 سال سے زائد عمر کے افراد میں پایا جاتا ہے، لیکن یہ نوجوانوں میں بھی دیکھا جاتا ہے۔ مرد اس بیماری سے زیادہ متاثر ہوتے ہیں، لیکن خواتین میں اس کا پھیلاؤ بڑھ رہا ہے۔خطرے کے عوامل: تمباکو نوشی پھیپھڑوں کے کینسر کا سب سے بڑا خطرہ ہے، جو مردوں میں 80% سے زیادہ اور عورتوں میں تقریباً 50% کیسز کا سبب بنتا ہے۔ دیگر خطرات میں سیکنڈ ہینڈ دھواں، پیشہ ورانہ خطرات (جیسے کہ ایسبیسٹوس اور ریڈون)، فضائی آلودگی، اور خاندانی تاریخ شامل ہیں۔علاقائی فرق: شہری علاقوں میں پھیپھڑوں کے کینسر کے واقعات زیادہ ہیں، جو کہ زیادہ تمباکو نوشی کی شرح اور ماحولیاتی آلودگی کی وجہ سے ہو سکتے ہیں۔ مغربی بنگال، دہلی، اور مہاراشٹر جیسے ریاستوں میں پھیپھڑوں کے کینسر کی شرح زیادہ ہے۔زندگی کی شرح: بھارت میں پھیپھڑوں کے کینسر کے مریضوں کی مجموعی پانچ سالہ بقا کی شرح کم ہے، تقریباً 15-20%، کیونکہ زیادہ تر کیسز دیر سے تشخیص ہوتے ہیں۔آگاہی اور اسکریننگ: پھیپھڑوں کے کینسر کی علامات کے بارے میں محدود آگاہی ہے، جس کی وجہ سے تشخیص میں تاخیر ہوتی ہے۔ اسکریننگ پروگرام وسیع پیمانے پر نافذ نہیں کیے گئے ہیں، جس کی وجہ سے دیر سے تشخیص ہوتی ہے۔یہ اعداد و شمار بھارت میں پھیپھڑوں کے کینسر کے بوجھ کو ظاہر کرتے ہیں اور بہتر آگاہی، بروقت تشخیص، اور بہتر علاج کے آپشنز کی ضرورت کو اجاگر کرتے ہیں۔

Lung cancer India .. statistics

Lung cancer

 is one of the most prevalent and deadly forms of cancer in India. Here are some key statistics:Incidence: Lung cancer is the second most common cancer in India among men and the fifth most common among women. 

Approximately 70,000 to 80,000 new cases are reported annually.Mortality: Lung cancer is the leading cause of cancer-related deaths in men in India.

 The mortality rate is high, with around 63,000 to 65,000 deaths each year.Age and Gender: The majority of lung cancer cases occur in individuals aged 60 and above. However, it is also seen in younger age groups. Men are more commonly affected than women, but the incidence among women has been rising.

Risk Factors: 

Tobacco smoking is the primary risk factor, accounting for over 80% of lung cancer cases in men and about 50% in women. 

Other risk factors include exposure to secondhand smoke, occupational hazards (like asbestos and radon), air pollution, and a family history of lung cancer.

Regional Variation: The incidence of lung cancer is higher in urban areas compared to rural areas, likely due to higher smoking rates and environmental pollution. Some states like West Bengal, Delhi, and Maharashtra report higher lung cancer rates.Survival Rate: The overall five-year survival rate for lung cancer in India is low, around 15-20%, mainly because most cases are diagnosed at an advanced stage.

Awareness and Screening: There is limited awareness about lung cancer symptoms, leading to delayed diagnosis. Screening programs are not widely implemented, contributing to late-stage detection.These statistics highlight the significant burden of lung cancer in India and the need for better awareness, early detection, and improved treatment options.

Online Consultation at a nominal fee . Can call ..6006052150

Screening for Urinary Tract Cancers.

What Are the Types of Urological Screening?

The screening methods employed for urological cancers are different for each specific type of cancer and are framed on the latest medical and research findings. The screening methods for different urological cancers are

• Prostate Cancer Screening - Prostate-specific antigen, PSA test, and digital rectal examination are commonly used for prostate screening. PSA protein is produced by the prostate gland, and increase in levels may indicate the presence of prostate cancer. Digital rectal examination is the physical examination of the prostate glands to detect its abnormalities. While these tests are valuable tools for detecting prostate cancer, they sometimes may give false positive results.

• Bladder Cancer Screening - Screening for bladder cancer often involves urine tests, such as urine cytology, to detect abnormal cells shed from the bladder lining. Additionally, urine-based tumor marker tests may be utilized to identify substances associated with bladder cancer. Imaging tests, such as cystoscopy. Cystoscopy is a procedure of inserting a thin, flexible tube with a camera into the bladder to visually inspect for abnormalities. Other diagnostic techniques like CT ( Computed Tomography) and MRI ( Magnetic Resonance Imaging) are the two modes of investigation used to assess the extent of the disease.

• Kidney Cancer Screening - Imaging tests like ultrasound, CT scans, or MRI are commonly used for kidney cancer screening. These imaging modalities allow healthcare professionals to see into the kidneys and surrounding structures. This enables the detection of any abnormalities or tumors. Screening may be recommended for individuals with risk factors such as a family history of kidney cancer or certain genetic conditions.

• Testicular Cancer Screening - Testicular self-examination (TSE) is a simple yet effective method for testicular cancer screening. Men are encouraged to regularly examine their testicles for any lump, swelling, or any changes that may indicate a problem. Medical evaluation is recommended if any abnormalities are detected during self-examination.

Global Cancer Scene is alarming

Global cancer statistics

provide insight into the burden of cancer worldwide, reflecting the incidence, mortality, and prevalence of different types of cancer. Here are some key points based on the most recent global data:Incidence:In 2020, there were approximately 19.3 million new cancer cases worldwide.

The most common cancers globally include breast cancer, lung cancer, colorectal cancer, prostate cancer, and stomach cancer.

Mortality:Cancer was responsible for nearly 10 million deaths in 2020, making it a leading cause of death worldwide.

Lung cancer remains the leading cause of cancer death, followed by colorectal, liver, stomach, and breast cancers.

Prevalence:

Breast cancer is the most prevalent cancer globally, with more than 7.8 million women diagnosed within the past five years.There is a significant geographic variation in cancer prevalence due to differences in risk factors, healthcare access, and population demographics.

Regional Variation:High-income countries tend to have higher cancer incidence rates but lower mortality rates due to better healthcare systems and early detection.Low- and middle-income countries have lower incidence rates but higher mortality rates due to limited access to early detection and treatment.

Risk Factors:Major risk factors for cancer include tobacco use, alcohol consumption, unhealthy diets, physical inactivity, and environmental factors.The aging population also contributes to the rising cancer incidence, as cancer is more common in older adults.

Future Projections:The global cancer burden is expected to increase to 28.4 million cases by 2040, due to population growth, aging, and changing risk factors.These statistics highlight the ongoing challenges in cancer prevention, diagnosis, and treatment worldwide. They also underscore the need for global efforts to reduce cancer risk factors, improve early detection, and ensure access to effective treatment for all populations.

Breast Cancer Sreening why,who and where

Screening for breast cancer

typically involves a series of steps aimed at detecting the disease early, when treatment is most likely to be successful.

 Here is a general screening protocol:

1. Risk Assessment 

Personal and Family History: Review the patient's history for any personal or familial risk factors, including genetic predispositions like BRCA1/2 mutations.

Age and Gender:

 Women are typically at higher risk; screenings usually start at age 40-50, depending on guidelines and individual risk factors.

2. Clinical Breast Exam (CBE)

Physical Examination: A healthcare professional examines the breasts for lumps, changes in size or shape, or any other unusual signs.

3. MammographyScreening Mammogram: 

X-ray imaging of the breast, recommended annually or biennially for women starting at age 40-50, depending on risk factors and guidelines.

Diagnostic Mammogram: Follow-up imaging for any abnormalities found during screening.

4. Additional Imaging TestsUltrasound: 

Often used to further evaluate findings from a mammogram, especially in women with dense breast tissue.

MRI: Recommended for high-risk individuals (e.g., those with a strong family history or genetic mutations).

5. Self-Exams and AwarenessBreast Self-Exams (BSE): 

Encouraging patients to be familiar with their own breasts so they can notice any changes.

Breast Awareness: 

Educating patients on the importance of knowing how their breasts normally look and feel.

6. Genetic Testing and CounselingGenetic Counseling:

 For individuals with a significant family history or other risk factors, genetic counseling and testing may be recommended.

7. Follow-Up and ReferralAbnormal Findings: If abnormalities are detected, a biopsy may be performed to diagnose the presence of cancer.Specialist Referral: Referral to a breast specialist, oncologist, or surgeon if necessary.

8. Screening IntervalsRoutine Screening: The frequency of screenings may vary based on age, risk factors, and prior findings. Generally, it is done annually or biennially.